Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP893647.RAbSfp16v3VBUFcCfguapr_1IBhiKQTUO3EFCqPlkFqiU130_assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893647.RAbSfp16v3VBUFcCfguapr_1IBhiKQTUO3EFCqPlkFqiU130_provenance.
• NP298593.RAivecW2h09iccxFd8TIVVEBfDFtn7vnrfNTBIo7FduTY130_assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298593.RAivecW2h09iccxFd8TIVVEBfDFtn7vnrfNTBIo7FduTY130_provenance.
• NP522385.RAgJJKp1MDAmiFr2dFG8CucW3sA1W2m7GwmZiSjVnKsVc130_assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522385.RAgJJKp1MDAmiFr2dFG8CucW3sA1W2m7GwmZiSjVnKsVc130_provenance.
• NP342164.RAxQ19H6Zum4uH9V0W7Jm2W2n4QoF6S4YRf8YgLziHLcc130_assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342164.RAxQ19H6Zum4uH9V0W7Jm2W2n4QoF6S4YRf8YgLziHLcc130_provenance.
• NP750909.RABBMNaIavBHP0gVnQROVWD0WskKIUiPLtSeyF9t6x3aE130_assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750909.RABBMNaIavBHP0gVnQROVWD0WskKIUiPLtSeyF9t6x3aE130_provenance.
• NP751549.RAVx84UOJLLAyHKz7mth5NiL-fIlQRfL-FRT3bsTvWpqg130_assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751549.RAVx84UOJLLAyHKz7mth5NiL-fIlQRfL-FRT3bsTvWpqg130_provenance.
• NP803634.RAXUFikr9sOLE-hba0AwqVVzKHKoTFJOMUD__udnzZVmE130_assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803634.RAXUFikr9sOLE-hba0AwqVVzKHKoTFJOMUD__udnzZVmE130_provenance.
• assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP803636.RAJv4oBDOZS--reOtCdopqeVjXDGHHSKdnQyzI3z1czI8130_assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803636.RAJv4oBDOZS--reOtCdopqeVjXDGHHSKdnQyzI3z1czI8130_provenance.
• NP752079.RAqPqMMJDlBejUGGhoo96qYx5eiUH5aEY-xyqo-x2iKr8130_assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752079.RAqPqMMJDlBejUGGhoo96qYx5eiUH5aEY-xyqo-x2iKr8130_provenance.
• NP803635.RAuJ_rQSfChMmlfBX4PLoq04AN8khUyoJxoV1LJDrSUlA130_assertion description "[The identification of LOH involving TP53 and RB1 loci is a novel finding in benign cutaneous neurofibromas possibly demonstrating an alternative underlying molecular mechanism associated with the development of these benign tumors from this cohort of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803635.RAuJ_rQSfChMmlfBX4PLoq04AN8khUyoJxoV1LJDrSUlA130_provenance.